share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4:持股變動聲明
SEC announcement ·  04/02 07:38
牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 03/28/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction was conducted under the issuer name and trading symbol PFIZER INC [PFE].
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 03/28/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction was conducted under the issuer name and trading symbol PFIZER INC [PFE].
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於2024年3月28日執行了一項交易。公告中未披露交易的具體細節,包括交易的股票數量、股票的性質、交易價格和股票的總價值。該報告也沒有提供有關Bourla在交易後持有的股票數量的信息。該交易以發行人的名稱和交易代碼輝瑞公司 [PFE] 進行。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於2024年3月28日執行了一項交易。公告中未披露交易的具體細節,包括交易的股票數量、股票的性質、交易價格和股票的總價值。該報告也沒有提供有關Bourla在交易後持有的股票數量的信息。該交易以發行人的名稱和交易代碼輝瑞公司 [PFE] 進行。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。